期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

15例炎性乳腺癌的综合治疗 被引量：1

Comprehensive Therapy of 15 Patients with Inflammatory Breast Cancer
暂未订购
导出
摘要 目的探讨炎性乳腺癌(IBC)的临床特点、疗效及预后。方法对15例IBC患者的临床资料进行回顾性分析。结果全组15例患者中,CR 3例,PR 8例,SD 3例,PD 1例,总有效率为73.3%;平均生存期26个月,1、3、5 a生存率分别为75.0%、58.3%、33.3%。结论 IBC恶性程度高,预后差,应采取综合治疗。 Objective To explore the clinical characteristics,treatment experience and prognosis of patients with inflammatory breast cancer （IBC）. Methods The Clinical data of 15 patients with IBC were reviewed retrospec- tively. Results Of the 15 cases,CR was observed in the 3 cases,PR in the 8 cases,SD in the 3 cases,PD in the 1 case,the response rate was 73.3%. The median survival time was 26 months. The 1-,3-,5-year survival rate was 75.0% ,58.3% ,33.3% respectively. Conclusion The prognosis of IBC is rather poor, the comprehensive treatment should be used.
作者 冯凌飞
机构地区 开封市第一人民医院
出处 《肿瘤基础与临床》 2013年第1期36-38,共3页 journal of basic and clinical oncology
关键词 炎性乳腺癌 综合治疗 新辅助化疗 inflammatory breast cancer comprehensive therapy neoadjuvant chemotherapy
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献5

  • 1杨威,胡虞乾,廖文胜,莫瑞祥.炎性乳癌13例综合治疗[J].实用医学杂志,2007,23(9):1361-1362. 被引量：2
  • 2Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemi- ology, and end results program at the National Cancer Institute [J]. J Natl Cancer Inst,2005,97(13) :966 -975.
  • 3Lopez MJ, Porter KA. Inflammatory breast cancer [ J ]. Surg Clin Noah Am, 1996,76 (2) :411 - 429.
  • 4Hennessy BT,Gonzalez-Angulo AM,Hortobagyi GN,et al. Disease- free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy [ J ]. Cancer,2006,106 (5) : 1000 - 1006.
  • 5Cristofanilli M, Valero V, Buzdar AU, et al. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biolo- av of a unicme disease [ J ]. Cancer.2007 , 110 (7) : 1436 - 1444.

二级参考文献1

共引文献1

同被引文献17

  • 1Li BD, Sicard MA, Ampil F, et al. Trimodal thera py for inflammatory breast cancer: a surgeon's perspective [J]. Oncology, 2010,79 ( 1/2 ) : 3-12.
  • 2Dawood S. Biology and management of inflammatory breast cancer [J]. Expert Rev Anticancer Ther, 2010,10(2) :209-220.
  • 3Arias-Pulido H, Chaher N, Gong Y, et al. Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer[J]. BMC Cancer,2012,12:298.
  • 4Kashiwagi S, Yashiro M, Takashima T,et al. Significance of E-cadherin expression in triple-negative breast cancer [J]. Br J Cancer, 2010,103 (2) : 249-255.
  • 5Lan C, Liu JM, Liu TW,et al. Erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+ in analysis [J]. Am J Clin Pathol, 2005,124( 1 ) :97-102.
  • 6Gong Y. Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype [J]. Semin Oncol, 2008,35 ( 1 ) : 33-40.
  • 7Ben Hamida A, Labidi IS, Mrad K,et al. Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin [ J ]. BMC Cancer, 2008,8 : 28.
  • 8Levine PH, Portera CC, Hoffman H J, et al. Evaluation oflymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer[J]. Clin Breast Cancer, 2012,12(4) :232-239.
  • 9yon Minckwitz G, Sinn HP, Raab G, et al. Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast[ J ]. Breast Cancer Res, 2008,10(2) :R30.
  • 10Aomatsu S, Abigail S, Kelly K, et al. Neoadjuvant systemic treatment of breast cancer [ J ]. J Surg Oncol, 2011,103 (4):348- 357.

引证文献1

二级引证文献1

肿瘤基础与临床
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部